Arbutus Biopharma Corp. buy quelbe60
Start price
23.01.22
/
50%
€2.30
Target price
23.01.23
-
Performance (%)
15.82%
End price
06.02.22
€2.66
Summary
This prediction ended on 06.02.22 with a price of €2.66. The prediction had a final performance of 15.82%. quelbe60 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Arbutus Biopharma Corp. | -0.156% | -0.156% | 13.113% |
| iShares Core DAX® | -0.992% | -3.231% | 11.661% |
| iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% |
| iShares Nikkei 225® | -0.736% | -7.859% | 18.597% |
| iShares S&P 500 | -0.509% | -2.979% | 26.341% |
According to quelbe60 what are the pros and cons of Arbutus Biopharma Corp. for the foreseeable future?
Pros
Cons
Risky Investment
Comments by quelbe60 for this prediction
In the thread Arbutus Biopharma Corp. diskutieren
Buy Arbutus Biopharma Corp.